ATE386724T1 - Substituierte hexahydrobenzo(a) phenanthridine - Google Patents

Substituierte hexahydrobenzo(a) phenanthridine

Info

Publication number
ATE386724T1
ATE386724T1 AT93914148T AT93914148T ATE386724T1 AT E386724 T1 ATE386724 T1 AT E386724T1 AT 93914148 T AT93914148 T AT 93914148T AT 93914148 T AT93914148 T AT 93914148T AT E386724 T1 ATE386724 T1 AT E386724T1
Authority
AT
Austria
Prior art keywords
phenanthridine
hydrogen
group
hexahydrobenzo
iodo
Prior art date
Application number
AT93914148T
Other languages
English (en)
Inventor
David E Nichols
Richard B Mailman
Original Assignee
Purdue Research Foundation
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation, Univ North Carolina filed Critical Purdue Research Foundation
Application granted granted Critical
Publication of ATE386724T1 publication Critical patent/ATE386724T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/18Ring systems of four or more rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT93914148T 1992-05-26 1993-05-26 Substituierte hexahydrobenzo(a) phenanthridine ATE386724T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88769292A 1992-05-26 1992-05-26

Publications (1)

Publication Number Publication Date
ATE386724T1 true ATE386724T1 (de) 2008-03-15

Family

ID=25391659

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93914148T ATE386724T1 (de) 1992-05-26 1993-05-26 Substituierte hexahydrobenzo(a) phenanthridine

Country Status (8)

Country Link
US (1) US5420134A (de)
EP (1) EP0644877B1 (de)
JP (1) JP3476193B2 (de)
KR (1) KR100292928B1 (de)
AT (1) ATE386724T1 (de)
AU (1) AU4391493A (de)
DE (1) DE69334206D1 (de)
WO (1) WO1993024462A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2193158T3 (es) * 1993-04-06 2003-11-01 Abbott Lab Compuestos tetraciclicos agonistas de la dopamina.
US5744476A (en) * 1994-06-27 1998-04-28 Interneuron Pharmaceuticals, Inc. Dopamine D1 agonists for the treatment of dementia
WO1996002513A1 (en) * 1994-07-15 1996-02-01 Purdue Research Foundation Optically active isomers of dihydrexidine and its substituted analogs
US5659037A (en) * 1994-08-18 1997-08-19 Abbott Laboratories Process for preparing chiral tetracyclic dopaminergic compounds
RU2177001C2 (ru) * 1995-08-18 2001-12-20 Пердью Рисерч Фаундейшн Новые конденсированные изохинолины в качестве лигандов для допаминовых рецепторов
US5668141A (en) * 1996-04-02 1997-09-16 Abbott Laboratories Trans-2,6-,3,6-and 4,6-diaza-5,6,6a,7,8,12b-hexahydrobenzo[c]phenanthrene compounds as dopamine agonists
US6541669B1 (en) * 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists
WO2003013532A1 (en) * 2001-08-10 2003-02-20 Purdue Research Foundation Chiral dinapsoline
DE60323339D1 (de) * 2002-02-15 2008-10-16 Darpharma Inc Monoester und asymmetrisch substituierte diester prodrugs der dopamin-d1-rezeptor-agonisten
US20070155720A1 (en) * 2003-12-23 2007-07-05 Darpharma, Inc. Co-administration of dopamine-receptor binding compounds
WO2007098462A2 (en) * 2006-02-21 2007-08-30 Purdue Research Foundation Trans-fused chromenoisoquinolines, synthesis and methods for use
EP2364317B1 (de) * 2008-08-05 2015-07-29 Effipharma, Inc. Dopaminrezeptorliganden mit verbesserter wirkungsdauer
WO2010124005A1 (en) 2009-04-21 2010-10-28 Purdue Research Foundation Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3912740A (en) * 1974-02-28 1975-10-14 Us Health Method for the preparation of oxygenated benzo{8 c{9 phenanthridine compounds
US3939165A (en) * 1974-11-14 1976-02-17 Morton-Norwich Products, Inc. 5,6,6A,6B,7,8-Hexahydrobenz[a]phenanthridine hydrochloride
US4737503A (en) * 1986-10-08 1988-04-12 Vipont Laboratories, Inc. Method for inhibiting the release of histamine
US5047536A (en) * 1989-03-17 1991-09-10 Purdue Research Foundation Hexahydrobenzo(A)phenanthridine compounds
IE912999A1 (en) * 1990-09-07 1992-03-11 Abbott Lab Phenanthridine compounds

Also Published As

Publication number Publication date
AU4391493A (en) 1993-12-30
KR950701623A (ko) 1995-04-28
DE69334206D1 (de) 2008-04-03
EP0644877A4 (de) 1995-02-03
US5420134A (en) 1995-05-30
EP0644877B1 (de) 2008-02-20
EP0644877A1 (de) 1995-03-29
JPH07507313A (ja) 1995-08-10
WO1993024462A1 (en) 1993-12-09
JP3476193B2 (ja) 2003-12-10
KR100292928B1 (ko) 2001-11-05

Similar Documents

Publication Publication Date Title
DE69334206D1 (de) Substituierte hexahydrobenzo(a) phenanthridine
ATE22084T1 (de) Ester von phosphinylalkanoyl-substituierten prolinen.
SE8704599L (sv) Teobrominderivat
ATE12224T1 (de) Verbindungen mit antifibrinolytischer wirksamkeit.
DK0607400T3 (da) Fluorerede 17beta-substituerede 4-aza-5-alfa-androstan-3-on-derivater
ATE42541T1 (de) Methyl-benzoylamino-2-hydroxy-acetate.
ES8403437A1 (es) Un procedimiento para obtener derivados de indanilbenzamida.
ES8707525A1 (es) Un procedimiento para la preparacion de nuevas isoindolinil-alquilpiperazinas
TW337985B (en) "N-(B-branched alkyl)-1, 2-benzisothiolin, 3ones, their preparation and their use as industrial biocides"
YU142791A (sh) Heterociklična jedinjenja
UA43338C2 (uk) Похідні бензолу
ES455909A1 (es) Procedimiento para preparar derivados de piperacina.
CA2084799A1 (en) Method of prevention of prostatic carcinoma with 17 beta-n-monosubstituted-carbamoyl-4-aza-5 alpha-androst-1 -en-3-ones
CA2135926A1 (en) Substituted hexahydrobenzo[a]phenanthridines
TW334337B (en) Preparation and composition for a compound of controlling and preventing phytopathogenic fungi
ES2103675A1 (es) Nuevas piperidinas sustituidas.
DE69217148D1 (de) Isoxazole derivate als lichtschutzmittel
ES8801542A1 (es) Procedimiento para preparar compuestos arilsulfonicos.
ES8606245A1 (es) Procedimiento para preparar fenoxianilinas y piridiloxianilinas sustituidas
TW238307B (en) Novel fruo pyrazole compounds
ES8107202A1 (es) Procedimiento para preparar nuevos derivados de oxadiazolin-1,3,4-ona-5.
MX9707201A (es) Derivados de 1-carba-(detia)-cefalosporina.
MX9801963A (es) Derivados de benzotiazolona.
TH36107A (th) สารประกอบชนิดใหม่

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties